| Year |
Citation |
Score |
| 2024 |
Gilhula JC, Xu L, White FD, Adelman SL, Aldrich KE, Batista ER, Dan D, Jones ZR, Kozimor SA, Mason HE, Meyer RL, Thiele NA, Yang P, Yuan M. Advances in heavy alkaline earth chemistry provide insight into complexation of weakly polarizing Ra, Ba, and Sr cations. Science Advances. 10: eadj8765. PMID 38181087 DOI: 10.1126/sciadv.adj8765 |
0.571 |
|
| 2022 |
Hou Z, Lockwood L, Zhang D, Occhiuto CJ, Mo L, Aldrich KE, Stoub HE, Gallo KA, Liby KT, Odom AL. Exploring structural effects in a new class of NRF2 inhibitors. Rsc Medicinal Chemistry. 14: 74-84. PMID 36760735 DOI: 10.1039/d2md00211f |
0.529 |
|
| 2022 |
Aldrich KE, Popov IA, Root HD, Batista ER, Greer SM, Kozimor SA, Lilley LM, Livshits MY, Mocko V, Janicke MT, Scott BL, Stein BW, Yang P. Synthesis, solid-state, solution, and theoretical characterization of an "in-cage" scandium-NOTA complex. Dalton Transactions (Cambridge, England : 2003). PMID 35739082 DOI: 10.1039/d1dt03887g |
0.616 |
|
| 2021 |
Aldrich KE, Livshits MY, Stromberg LR, Janicke MT, Nhu Lam M, Stein B, Wagner GL, Abergel RJ, Mukundan H, Kozimor SA, Lilley LM. Th-Desferrioxamine: characterization of a fluorescent bacterial probe. Dalton Transactions (Cambridge, England : 2003). 50: 15310-15320. PMID 34636377 DOI: 10.1039/d1dt02177j |
0.523 |
|
| 2021 |
Zhang D, Hou Z, Aldrich KE, Lockwood L, Odom AL, Liby KT. A novel Nrf2 pathway inhibitor sensitizes Keap1-mutant lung cancer cells to chemotherapy. Molecular Cancer Therapeutics. PMID 34158350 DOI: 10.1158/1535-7163.MCT-21-0210 |
0.482 |
|
| 2020 |
Aldrich KE, Lam MN, Eiroa-Lledo C, Kozimor SA, Lilley LM, Mocko V, Stein BW. Preparation of an Actinium-228 Generator. Inorganic Chemistry. PMID 32062965 DOI: 10.1021/Acs.Inorgchem.9B03563 |
0.644 |
|
| 2019 |
Aldrich KE, Kansal D, Odom AL. Catalyst design insights from modelling a titanium-catalyzed multicomponent reaction. Faraday Discussions. PMID 31528974 DOI: 10.1039/C9Fd00033J |
0.596 |
|
| 2019 |
Aldrich KE, Fales BS, Singh AK, Staples RJ, Levine BG, McCracken J, Smith MR, Odom AL. Electronic and Structural Comparisons between Iron(II/III) and Ruthenium(II/III) Imide Analogs. Inorganic Chemistry. PMID 31403782 DOI: 10.1021/Acs.Inorgchem.9B01672 |
0.714 |
|
| 2019 |
Aldrich KE, Odom AL. A silica-supported titanium catalyst for heterogeneous hydroamination and multicomponent coupling reactions. Dalton Transactions (Cambridge, England : 2003). PMID 31281914 DOI: 10.1039/C9Dt01835B |
0.5 |
|
| 2019 |
Aldrich KE, Odom AL. A photochemical route to a square planar, ruthenium(iv)-bis(imide). Chemical Communications (Cambridge, England). PMID 30916084 DOI: 10.1039/C9Cc01019J |
0.563 |
|
| 2019 |
Zhang D, Aldrich K, Dexheimer T, Ellsworth E, Odom A, Liby K. Abstract C063: A novel Nrf2 inhibitor suppresses proliferation and enhances the sensitivity of cancer cells to chemotherapy Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-C063 |
0.535 |
|
| 2019 |
Aldrich KE, Billow BS, Staples RJ, Odom AL. Phosphine interactions with high oxidation state metals Polyhedron. 159: 284-297. DOI: 10.1016/J.Poly.2018.11.027 |
0.72 |
|
| 2018 |
Aldrich KE, Odom AL. Titanium-Catalyzed Hydroamination and Multicomponent Coupling with a Simple Silica-Supported Catalyst Organometallics. 37: 4341-4349. DOI: 10.1021/Acs.Organomet.8B00313 |
0.534 |
|
| 2017 |
Aldrich KE, Billow BS, Holmes D, Bemowski RD, Odom AL. Weakly Coordinating yet Ion Paired: Anion Effects on an Internal Rearrangement Organometallics. 36: 1227-1237. DOI: 10.1021/Acs.Organomet.6B00839 |
0.573 |
|
| Show low-probability matches. |